Eli Lilly and Company’s Lower-Priced Insulin Now Available

Eli Lilly and Company announced its generic, half-priced version of Humalog insulin is now available for order in pharmacies across the U.S. The …

LifeScan and Sanvita Medical Partner to Launch Continuous Glucose Monitoring Devices

LifeScan, a leader in blood glucose monitoring and maker of the OneTouch® brand announced it has entered into an exclusive agreement with Sanvita …

FDA Gives INVOKANA® Priority Review to Treat Chronic Kidney Disease in Patients with T2D

Janssen Pharmaceutical, a Johnson and Johnson company, announced the U.S. Food and Drug Administration (FDA) has granted priority review for the …

FDA Warns Against the Use of “DIY” Diabetes Management Devices

The U.S. Food and Drug Administration (FDA) has issued a warning about the use of unapproved devices for diabetes management, so-called …

Company Reversing Type 2 Diabetes Aims to Help U.S. Veterans

Virta Health, a company aiming to safely and sustainably reverse Type 2 diabetes without medications or surgery, today announced an innovative …

“Smart” Insulin Could Prevent Hypoglycemia During Diabetes Treatment

Bioengineers at the University of California, Los Angeles have developed a new type of insulin that could help prevent hypoglycemia in people who use …

Weighing In on Weight-loss Surgery for Teens to Improve Type 2 diabetes; Health Outcomes

New results from an NIH-funded study finds that teens who had gastric bypass surgery were significantly more likely to have remission of both Type …

Diabetes Linked to Numerous Cancers in Large Chinese Study

A new study from China found that Type 2 diabetes was linked with an elevated risk of 11 types of cancer in men and 13 types of cancer in women. The …

FDA Approves New Injection for Diabetic Retinopathy

Regeneron Pharmaceuticals, Inc. announced yesterday that the U.S. Food and Drug Administration (FDA) has approved EYLEA® (aflibercept) Injection to …

Review Sheds New Light on Gangrene Cases Linked to Patients on SGLT2 Diabetes Drugs

A new review of Fournier Gangrene cases associated with SGLT2 diabetes drugs conducted by researchers is shedding new light on the occurrence of …